Advances in basic research,clinical diagnosis and treatment of pancreatic cancer in 2023
10.19401/j.cnki.1007-3639.2024.01.001
- VernacularTitle:2023年度胰腺癌研究及诊疗新进展
- Author:
Tianjiao LI
1
;
Longyun YE
;
Kaizhou JIN
;
Weiding WU
;
Xianjun YU
Author Information
1. 复旦大学附属肿瘤医院胰腺外科,复旦大学上海医学院肿瘤学系,复旦大学胰腺肿瘤研究所,上海市胰腺肿瘤研究所,上海 200032
- Keywords:
Pancreatic cancer;
Epidemiology;
Basic research;
Clinical research
- From:
China Oncology
2024;34(1):1-13
- CountryChina
- Language:Chinese
-
Abstract:
Pancreatic cancer is a highly malignant digestive tract tumor with hidden symptoms,limited treatment options and rapid progression.With an increasing incidence rate year by year,pancreatic cancer has increasingly become a prominent issue endangering public health,causing a huge social burden.Although there was no significant improvement in survival rates for pancreatic cancer patients in the past two decades,recent progress in epidemiology,basic research and clinical research of pancreatic cancer has accelerated significantly compared to the past.Some findings have already enabled a small proportion of pancreatic cancer patients to achieve better survival.This article provided a review of the significant progress made in research,diagnosis and treatment of pancreatic cancer in 2023.
